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Background
CaV1.3 channels, which belong to the family of voltage-
gated L-type calcium channels (LTCCs), are involved in
important physiological (e.g. hearing, hormone release and
cardiac and neuronal pace making) and pathophysiological
functions (e.g. Parkinson’s disease). We have recently dis-
covered that an intramolecular protein interaction within
the C-terminus of CaV1.3 a1 subunits fine-tunes CaV1.3
channel function. This C-terminal modulatory mechanism
(CTM) is present in the long (CaV1.3l) but is absent in the
short (CaV1.342A) splice variant. Its absence induces activa-
tion at a more negative voltage range and increases Ca
2
+-dependent inactivation (CDI). Interestingly a functional
CTM is present in the human [1] and rat CaV1.3 a1s u b u -
nit isolated from pancreatic islets (D38101, rCaV1.3pan)
but not in a rat CaV1.3 a1 subunit cDNA clone isolated
from superior cervical ganglion (scg) (AF370010;
rCaV1.3scg). This causes substantial differences in the vol-
tage- and Ca
2+-dependent gating of scg and pan.
Methods
We systematically compared scg and pan CaV1.3 a1s u b u -
nits by expression in tsA201 cells and analysis of their
functional properties using the whole-cell patch-clamp
technique, to determine the structural basis for this
difference.
Results
rCaV1.3scg differs from rCaV1.3pan at three amino acid
positions (S244G, V1104A, A2073V) and one alternatively
spliced locus (absence of exon 31). Alternative splicing did
not explain the functional differences between the two
rCaV1.3 a1 subunits. The amino acid difference A2073V is
located within the recently identified distal part (DCRD) of
a C-terminal modulatory domain. Mutation of A2073 in
rCaV1.3scg to the corresponding valine (A2073V) in
rCaV1.3pan fully restores the slower CDI of rCaV1.3pan.
In contrast, A2073V only weakly affected the activation
voltage range (rescue of only 5.3 mV of the 17.2 mV dif-
ference in the half-maximal voltage activation range (Vh)).
Additional mutation of S244 to G in the rCaV1.3scg S4-S5
linker of domain I caused a further shift to a more positive
voltage close to the Vh of rCaV1.3pan.
Conclusions
Our data identify residues at proposed interfaces
between voltage sensors and the intracellular channel
gate controlling the voltage-dependence of CaV1.3 acti-
vation. We also show that the DCRD domain can mod-
erate CDI independently of its effect on Vh,s u g g e s t i n g
that these processes occur through different DCRD-
dependent mechanisms.
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